AstraZeneca’s chief executive, Pascal Soriot, received a pay package of nearly £17m last year, cementing his position as one of the best-paid FTSE 100 bosses as he drew criticism from corporate governance experts.
Soriot, 64, who has made nearly £120m in the decade since he took the helm at the drugmaker in October 2012, was paid £16.9m last year, including salary, benefits and bonuses, up from £15.3m the year before, according to AstraZeneca’s annual report.
